Coeliac disease is widespread. It must be very difficult living your life, strictly watching what you eat. Indeed, many are not diagnosed and go through life suffering. But now there is hope. A research team at Monash university has identified problem protein fragments that cause the disease. Soon treatments will be developed that allow sufferers to consume products that contain gluten.
The research was a combined work between the Victorian Coeliac Society and the John Radcliffe hospital in the UK. Three gluten peptide fragments were observed as being the most toxic in tests, while some 90 fragment caused some reaction in sufferers.
Nexpep Pty Ltd has already developed an immunotherapy that desensitizes people to gluten. This is possible because the three "culprits" are now known.
The research was a combined work between the Victorian Coeliac Society and the John Radcliffe hospital in the UK. Three gluten peptide fragments were observed as being the most toxic in tests, while some 90 fragment caused some reaction in sufferers.
Nexpep Pty Ltd has already developed an immunotherapy that desensitizes people to gluten. This is possible because the three "culprits" are now known.
